Apheresis Market CAGR is expected to be 7.82% during the forecast period and the market size is expected to reach nearly US$ 3.23 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology :- Request Free Sample Report Apheresis is the medical technology which is used for the purification of the blood or separation of different components of blood. It involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is sent back to the donor or patients. The rising prevalence of diseases and a growing number of trauma and injury cases, increasing demand for source plasma from biopharmaceutical companies, and the presence of a favorable reimbursement scenario for apheresis would create commercial market opportunities. Untapped emerging regions showcase new growth opportunities for this market. Lack of awareness about apheresis and the high cost of these procedures. Blood and blood products can get infected easily. This risk along with a lack of skilled professionals is the major hindrance for market growth. Apheresis market is segmented by product, procedure, technology, application, and region. Among products, plasma component separators is considered an attractive market segment and are expected to hold a significant share of the market in the coming years. Growth can be attributed to factors such as the increase in incidence rate of chronic disorders and weak immune system among people. Immunoadsorption Columns segment would continue to dominate the market during the forecast period owing to the growing demand for kidney transplantation. Among the procedure segment, therapeutic apheresis is considered an attractive market segment and is expected to hold a significant share of the market in the coming years. It is used for the treatment of conditions in which a pathogenic substance or component in the blood is causing morbidity. Growth can be attributed to factors such as the treatment of conditions in which a pathogenic substance or component in the blood is causing morbidity. Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to increasing applications of apheresis products in plasma collection and fractionation. The presence of established distribution channels and the growing focus on apheresis blood collection to overcome blood shortage is driving the market growth in this region. The Asia Pacific is expected to grow rapidly due to rapid development in healthcare and increasing healthcare expenditure. The major key players in Apheresis market include Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). In 2018, Fresenius Medical Care achieved a preclinical milestone in its regenerative medicine program for chronic kidney disease.
Apheresis Market report Scope:Inquire before buying
Global Apheresis Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.76 Bn. Forecast Period 2022 to 2029 CAGR: 7.82 % Market Size in 2029: US $ 3.23 Bn. Segments Covered: by Product • Apheresis Devices o Plasma Separators o Plasma Component Separators o Immunoadsorption Columns o Plasma Perfusion Columns o Hemoperfusion Columns • Apheresis Disposables • Apheresis Market, by Procedure • Automated/Apheresis Blood Collection (Donor Apheresis) • Therapeutic Apheresis by Disease Neurological Disorders Blood Disorders Cardiovascular Disorders Renal Disorders Autoimmune Disorders Metabolic Disorders Other Disorders by Procedure • Therapeutic Plasma Exchange (TPE) • Therapeutic Cytapheresis Therapeutic Erythrocytapheresis Therapeutic Plateletpheresis Leukapheresis • Photopheresis • Extracorporeal Immunoadsorption (ECI) by Technology • Centrifugation Intermittent Flow Continuous Flow • Membrane Separation by Application • Plasmapheresis • Plateletpheresis • Erythrocytapheresis • Leukapheresis • Other Applications
Apheresis market, by Region• North America • Europe • APAC • Latin America • MEA
Apheresis Market Key Players:• Haemonetics Corporation • Fresenius Medical Care • Terumo BCT, Inc. • Asahi Kasei Medical Co., Ltd. • Kawasumi Laboratories Inc. • Cerus Corporation • B. Braun Melsungen AG • HemaCare Corporation • Kaneka Corporation • Nikkiso Co., Ltd. Frequently Asked Questions: 1. Which region has the largest share in Global Apheresis Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Apheresis Market? Ans: The Global Apheresis Market is growing at a CAGR of 7.82% during forecasting period 2022-2027. 3. What is scope of the Global Apheresis market report? Ans: Global Apheresis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Apheresis market? Ans: The important key players in the Global Apheresis Market are – Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, HemaCare Corporation, Kaneka Corporation, Nikkiso Co., and Ltd. 5. What is the study period of this market? Ans: The Global Apheresis Market is studied from 2021 to 2027.
1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 126.96.36.199 Paid 188.8.131.52 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Apheresis Market Overview 3.1.1 Apheresis Market : By Product 3.1.2 Apheresis Market : By Application 3.1.3 Apheresis Market : By Technology 3.1.4 Apheresis Market : By Procedure 3.1.5 Apheresis Market : By Region 4. APHERESIS MARKET OUTLOOK 4.1 Apheresis Market : Market Definition, Segmentation and Scope of Study 4.2 Apheresis Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Apheresis Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Apheresis Market : Porter’s Analysis 4.5 Apheresis Market : PESTEL Analysis 4.6 Apheresis Market : Product Benchmark Analysis 4.7 Apheresis Market : Company Market Share Analysis 4.8 Apheresis Market : Key Findings 4.8.1 Apheresis Market : Top Wining Strategies 4.8.2 Apheresis Market : Top Investment Pockets 4.8.3 Apheresis Market : Top Impacting Factors 5. APHERESIS MARKET, BY PRODUCT 5.1 Apheresis Market : Product segment Market Share analysis 5.2 Apheresis Market : Product segment Market Size and Forecast 2021-2029 5.3 Apheresis Market by Apheresis Devices 5.4 Apheresis Market by Apheresis Disposables 5.5 Apheresis Market Benchmarking By Product 5.6 Apheresis Market by Product : Key Trends 5.7 Apheresis Market by Product : Key Developments 6. APHERESIS MARKET , BY APPLICATION 6.1 Apheresis Market : application segment Market Share Analysis 6.2 APHERESIS MARKET : application segment Market Size and Forecast 2021-2029 6.3 Apheresis Market by Plasmapheresis 6.4 Apheresis Market by Plateletpheresis 6.5 Apheresis Market by Erythrocytapheresis 6.6 Apheresis Market by Leukapheresis 6.7 Apheresis Market by Other Applications 6.8 Apheresis Market by Supply chain management 6.9 Apheresis Market Benchmarking By Application 6.10 Apheresis Market by Application: Key Trends 6.11 Apheresis Market by Application: Key Developments 7. APHERESIS MARKET, BY TECHNOLOGY 7.1 Apheresis Market : Technology segment Market Share analysis 7.2 Apheresis Market : Technology segment Market Size and Forecast 2021-2029 7.3 Apheresis Market by Centrifugation 7.4 Apheresis Market by Membrane Separation 7.5 Apheresis Market Benchmarking By Technology 7.6 Apheresis Market by Technology: Key Trends 7.7 Apheresis Market by Technology: Key Developments 8. APHERESIS MARKET , BY PROCEDURE 8.1 Apheresis Market : Procedure segment Market Share Analysis 8.2 Apheresis Market : Procedure segment Market Size and Forecast 2021-2029 8.3 Apheresis Market by Automated/Apheresis Blood Collection 8.4 Apheresis Market by Therapeutic Apheresis 8.5 Apheresis Market by Therapeutic Plasma Exchange 8.6 Apheresis Market by Therapeutic Cytapheresis 8.7 Apheresis Market by Therapeutic Cytapheresis 8.8 Apheresis Market by Photopheresis 8.9 Apheresis Market by Extracorporeal Immunoadsorption 8.10 Apheresis Market Benchmarking By Procedure 8.11 Apheresis Market by Procedure : Key Trends 8.12 Apheresis Market by Procedure : Key Developments 9. APHERESIS MARKET , BY GEOGRAPHY 9.1 Apheresis Market : Geography segment Market Share Analysis 9.2 Apheresis Market : Geography segment Market Size and Forecast 2021-2029 9.3 North America 9.3.1 Overview 9.3.2 Apheresis Market Size and Forecast, by Product 2021-2029 9.3.3 Apheresis Market Share Analysis , by Product 2021-2029 9.3.4 Apheresis Market Size and Forecast, by Application 2021-2029 9.3.5 Apheresis Market Share Analysis , by Application 2021-2029 9.3.6 Apheresis Market Size and Forecast, by Technology 2021-2029 9.3.7 Apheresis Market Share Analysis , by Technology 2021-2029 9.3.8 Apheresis Market Size and Forecast, by Procedure 2021-2029 9.3.9 Apheresis Market Share Analysis , by Procedure 2021-2029 9.4 Europe 9.4.1 Overview 9.4.2 Apheresis Market Size and Forecast, by Product 2021-2029 9.4.3 Apheresis Market Share Analysis , by Product 2021-2029 9.4.4 Apheresis Market Size and Forecast, by Application 2021-2029 9.4.5 Apheresis Market Share Analysis , by Application 2021-2029 9.4.6 Apheresis Market Size and Forecast, by Technology 2021-2029 9.4.7 Apheresis Market Share Analysis , by Technology 2021-2029 9.4.8 Apheresis Market Size and Forecast, by Procedure 2021-2029 9.4.9 Apheresis Market Share Analysis , by Procedure 2021-2029 9.5 Asia Pacific 9.5.1 Overview 9.5.2 Apheresis Market Size and Forecast, by Product 2021-2029 9.5.3 Apheresis Market Share Analysis , by Product 2021-2029 9.5.4 Apheresis Market Size and Forecast, by Application 2021-2029 9.5.5 Apheresis Market Share Analysis , by Application 2021-2029 9.5.6 Apheresis Market Size and Forecast, by Technology 2021-2029 9.5.7 Apheresis Market Share Analysis , by Technology 2021-2029 9.5.8 Apheresis Market Size and Forecast, by Procedure 2021-2029 9.5.9 Apheresis Market Share Analysis , by Procedure 2021-2029 9.6 Latin America, Middle East and Africa 9.6.1 Overview 9.6.2 Apheresis Market Size and Forecast, by Product 2021-2029 9.6.3 Apheresis Market Share Analysis , by Product 2021-2029 9.6.4 Apheresis Market Size and Forecast, by Application 2021-2029 9.6.5 Apheresis Market Share Analysis , by Application 2021-2029 9.6.6 Apheresis Market Size and Forecast, by Technology 2021-2029 9.6.7 Apheresis Market Share Analysis , by Technology 2021-2029 9.6.8 Apheresis Market Size and Forecast, by Procedure 2021-2029 9.6.9 Apheresis Market Share Analysis , by Procedure 2021-2029 9.7 Apheresis Market Benchmarking By Geography 9.8 Apheresis Market by Geography : Key Trends 9.9 Apheresis Market by Geography : Key Developments 10. COMPETITIVE LANDSCAPE 10.1 Apheresis Market Share/ Positioning Analysis 10.2 Apheresis Market: Key Innovators 10.3 Apheresis Market : Company Profiles 10.3.1 Haemonetics Corporation 10.3.1.1 Overview 10.3.1.2 Product/Service Portfolio 10.3.1.3 Key Financials 10.3.1.4 Strategic Initiatives 10.3.1.5 SWOT Analysis 10.3.1.6 Competitive Assessment 10.3.2 Fresenius Medical Care 10.3.2.1 Overview 10.3.2.2 Product/Service Portfolio 10.3.2.3 Key Financials 10.3.2.4 Strategic Initiatives 10.3.2.5 SWOT Analysis 10.3.2.6 Competitive Assessment 10.3.3 Terumo BCT, Inc. 10.3.3.1 Overview 10.3.3.2 Product/Service Portfolio 10.3.3.3 Key Financials 10.3.3.4 Strategic Initiatives 10.3.3.5 SWOT Analysis 10.3.3.6 Competitive Assessment 10.3.4 Asahi Kasei Medical Co., Ltd. 10.3.4.1 Overview 10.3.4.2 Product/Service Portfolio 10.3.4.3 Key Financials 10.3.4.4 Strategic Initiatives 10.3.4.5 SWOT Analysis 10.3.4.6 Competitive Assessment 10.3.5 Kawasumi Laboratories Inc. 10.3.5.1 Overview 10.3.5.2 Product/Service Portfolio 10.3.5.3 Key Financials 10.3.5.4 Strategic Initiatives 10.3.5.5 SWOT Analysis 10.3.5.6 Competitive Assessment 10.3.6 Cerus Corporation 10.3.6.1 Overview 10.3.6.2 Product/Service Portfolio 10.3.6.3 Key Financials 10.3.6.4 Strategic Initiatives 10.3.6.5 SWOT Analysis 10.3.6.6 Competitive Assessment 10.3.7 B. Braun Melsungen AG 10.3.7.1 Overview 10.3.7.2 Product/Service Portfolio 10.3.7.3 Key Financials 10.3.7.4 Strategic Initiatives 10.3.7.5 SWOT Analysis 10.3.7.6 Competitive Assessment 10.3.8 HemaCare Corporation 10.3.8.1 Overview 10.3.8.2 Product/Service Portfolio 10.3.8.3 Key Financials 10.3.8.4 Strategic Initiatives 10.3.8.5 SWOT Analysis 10.3.8.6 Competitive Assessment 10.3.9 Kaneka Corporation 10.3.9.1 Overview 10.3.9.2 Product/Service Portfolio 10.3.9.3 Key Financials 10.3.9.4 Strategic Initiatives 10.3.9.5 SWOT Analysis 10.3.9.6 Competitive Assessment 10.3.10 Nikkiso Co., Ltd. 10.3.10.1 Overview 10.3.10.2 Product/Service Portfolio 10.3.10.3 Key Financials 10.3.10.4 Strategic Initiatives 10.3.10.5 SWOT Analysis 10.3.10.6 Competitive Assessment 11. CONSOLIDATION 11.1 Apheresis Market: Mergers and Acquisitions 11.1.1 Overview 11.1.2 Apheresis Market : Key Drivers – By Region 11.1.3 Apheresis Market : M&A Breakdown 184.108.40.206 Product Based 220.127.116.11 Procedure Based 18.104.22.168 Technology Based 22.214.171.124 Application Based 126.96.36.199 Niche Based 188.8.131.52 Region Based 184.108.40.206 Asset & Non-Asset Based 220.127.116.11 Venture Capitalist Based 11.2 Fragmentation of Apheresis Market 11.3 Apheresis Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 11.4 Apheresis Market - New/Emerging Models of Partnerships : Key Examples 11.5 Apheresis Market : New/Emerging Business Models : Key Examples 11.6 Apheresis Market - Changing Investment Paradigm : Focused areas by Key Players 11.7 Apheresis Market - Patent Analysis 12. APHERESIS MARKET : LIST OF TABLES 13. APHERESIS MARKET: LIST OF FIGURES